Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
540.00    -13.00 (-2.35%)
Bid:
541.00
Ask:
543.00
Spread: 2.00 (0.37%)
Market Cap: £995.07m
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Holding(s) in Company

29 Jun 2009 16:05

RNS Number : 7046U
Volex Group PLC
29 June 2009
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Volex Group plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No 

An event changing the breakdown of voting rights

No 

Other (please specify):

 No

3. Full name of person(s) subject to the notification obligation:

 Gartmore Investment Limited

4. Full name of shareholder(s) (if different from 3.):

See box 9.

5. Date of the transaction and date on which the threshold is crossed or reached:

 25th June 2009

6. Date on which issuer notified:

 29th June 2009

7. Threshold(s) that is/are crossed or reached:

 5%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 

GB0009390070

N/A

 N/A

5,120,000

 

5,120,000

 

 8.998%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/  Conversion  Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise  price

Expiration  date

Exercise/ Conversion  period

Number of voting  rights instrument  refers to

% of voting rights

 

 

 

 

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 5,120,000

 8.998%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Fund Managing Co.

Shares Held

% of Issued Share Capital

UK Registered Owner

Beneficial Owner

Gartmore Fund Managers Limited

500,000

0.879%

HSBC Global Custody Nominee UK Ltd

Gartmore Fund Managers Ltd A/C Gartmore UK & Irish Smaller Companies

Gartmore Investment Limited

1,000,000

1.757%

Nortrust Nominees Limited

Strathclyde Pension Fund

2,620,000

4.604%

BNY GIL CLT Account Nominees Ltd

Gartmore Fledgling Trust Plc

1,000,000

1.757%

Vidacos Nominees Ltd A/c 2303

The Alphagen Volantis Fund Limited

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

The share interests disclosed are based on the Company's issued share capital of 56,901,563.

14. Contact name:

 Wendy Tate

15. Contact telephone number:

 01925 830 101

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBUGDLSGDGGCC
Date   Source Headline
25th Jun 20267:00 amRNSPreliminary Group Results FY2026
25th Jun 20267:00 amRNSUpdate on Move to the Main Market
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.